Takaisin Tulosta

Sepelvaltimotautikohtaus, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
23.3.2022

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Sepelvaltimotautikohtaus «Sepelvaltimotautikohtaus»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Aasa M, Dellborg M, Herlitz J ym. Risk reduction for cardiac events after primary coronary intervention compared with thrombolysis for acute ST-elevation myocardial infarction (five-year results of the Swedish early decision reperfusion strategy [SWEDES] trial). Am J Cardiol 2010;106(12):1685-91.
  2. Abdelnoor M, Andersen JG, Arnesen H ym. Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost. Vasc Health Risk Manag 2017;13:101-109 «PMID: 28356750»PubMed
  3. Agarwal JB, Khaw K, Aurignac F ym. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram. Am J Cardiol 1999;83:323-6 «PMID: 10072216»PubMed
  4. Alexander KP, Newby LK, Bhapkar MV ym. International variation in invasive care of the elderly with acute coronary syndromes. Eur Heart J 2006;27:1558-64 «PMID: 16760200»PubMed
  5. Alexander KP, Newby LK, Cannon CP ym. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007;115:2549-69 «PMID: 17502590»PubMed
  6. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97 «PMID: 12479763»PubMed
  7. Andersen HR, Nielsen TT, Rasmussen K ym. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42 «PMID: 12930925»PubMed
  8. Anderson L, Oldridge N, Thompson DR ym. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol 2016;67:1-12 «PMID: 26764059»PubMed
  9. Antithrombotic Trialists' Collaboration.. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86 «PMID: 11786451»PubMed
  10. Aradi D, Komócsi A, Vorobcsuk A ym. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J 2010;160:543-51 «PMID: 20826265»PubMed
  11. Bach RG, Cannon CP, Weintraub WS ym. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004;141:186-95 «PMID: 15289215»PubMed
  12. Bandstein N, Ljung R, Johansson M ym. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014;63:2569-2578 «PMID: 24694529»PubMed
  13. Bangalore S, Makani H, Radford M ym. Clinical outcomes with ß-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 2014;127:939-53 «PMID: 24927909»PubMed
  14. Bangalore S, Messerli FH, Cohen JD ym. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. Am Heart J 2008;156:241-7 «PMID: 18657652»PubMed
  15. Bangalore S, Steg G, Deedwania P ym. ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012;308:1340-9 «PMID: 23032550»PubMed
  16. Bao B, Ozasa N, Morimoto T ym. ß-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther 2013;28:139-47 «PMID: 23054967»PubMed
  17. Barbarawi M, Kheiri B, Zayed Y ym. Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome. Catheter Cardiovasc Interv 2020;95:185-193 «PMID: 31111670»PubMed
  18. Biener M, Mueller M, Vafaie M ym. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013;167:1134-40 «PMID: 23063209»PubMed
  19. Boersma E, Primary Coronary Angioplasty vs. Thrombolysis Group.. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-88 «PMID: 16513663»PubMed
  20. Bonnefoy E, Lapostolle F, Leizorovicz A ym. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-9 «PMID: 12243916»PubMed
  21. Bonnefoy E, Steg PG, Boutitie F ym. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009;30:1598-606 «PMID: 19429632»PubMed
  22. Brieger D, Collet JP, Silvain J ym. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2011;77:182-90 «PMID: 20578166»PubMed
  23. Buber J, Goldenberg I, Kimron L ym. One-year outcome following coronary angiography in elderly patients with non-ST elevation myocardial infarction: real-world data from the Acute Coronary Syndromes Israeli Survey (ACSIS). Coron Artery Dis 2013;24:102-9 «PMID: 23242010»PubMed
  24. Bularga A, Lee KK, Stewart S ym. High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome. Circulation 2019;140:1557-1568 «PMID: 31475856»PubMed
  25. Busk M, Maeng M, Rasmussen K ym. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 2008;29:1259-66 «PMID: 17956874»PubMed
  26. Cairns JA, Gent M, Singer J ym. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985;313:1369-75 «PMID: 3903504»PubMed
  27. Cannon CP, Pratley R, Dagogo-Jack S ym. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes. N Engl J Med 2020;383:1425-1435 «PMID: 32966714»PubMed
  28. Cannon CP, Weintraub WS, Demopoulos LA ym. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87 «PMID: 11419424»PubMed
  29. Casas RE, Marriott HJ, Glancy DL. Value of leads V7-V9 in diagnosing posterior wall acute myocardial infarction and other causes of tall R waves in V1-V2. Am J Cardiol 1997;80:508-9 «PMID: 9285667»PubMed
  30. Castaigne AD, Hervé C, Duval-Moulin AM ym. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989;64:30A-33A; discussion 41A-42A «PMID: 2662741»PubMed
  31. Chang AM, Shofer FS, Tabas JA ym. Lack of association between left bundle-branch block and acute myocardial infarction in symptomatic ED patients. Am J Emerg Med 2009;27:916-21 «PMID: 19857407»PubMed
  32. Chatterjee S, Chaudhuri D, Vedanthan R ym. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol 2013;168:915-21 «PMID: 23168009»PubMed
  33. Chen ZM, Jiang LX, Chen YP ym. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21 «PMID: 16271642»PubMed
  34. Chen ZM, Pan HC, Chen YP ym. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1622-32 «PMID: 16271643»PubMed
  35. Chow CK, Jolly S, Rao-Melacini P ym. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010;121:750-8 «PMID: 20124123»PubMed
  36. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106 «PMID: 8298418»PubMed
  37. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97 «PMID: 12837716»PubMed
  38. Cuisset T, Frere C, Quilici J ym. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol 2006;48:1339-45 «PMID: 17010792»PubMed
  39. D'Andrea E, Kesselheim AS, Franklin JM ym. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol 2020;19:154 «PMID: 32993654»PubMed
  40. Dedic A, Lubbers MM, Schaap J ym. Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. J Am Coll Cardiol 2016;67:16-26 «PMID: 26764061»PubMed
  41. Elgendy IY, Elgendy AY, Mahmoud AN ym. Intravenous ß-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol 2016;223:891-897 «PMID: 27584567»PubMed
  42. Engstrøm T, Kelbæk H, Helqvist S ym. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet 2015;386:665-71 «PMID: 26347918»PubMed
  43. Eskola M. Use of the 12-lead Electrocardiogram in Selecting Reperfusion Therapy for ST-elevation Myocardial Infarction. Acta Universitatis Tamperensis; 1353, Tampere University Press, Tampere 2008
  44. Eskola MJ, Holmvang L, Nikus KC ym. The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial. Eur Heart J 2007;28:2985-91 «PMID: 17932102»PubMed
  45. Ettehad D, Emdin CA, Kiran A ym. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957-967 «PMID: 26724178»PubMed
  46. European Myocardial Infarction Project Group.. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9 «PMID: 8326971»PubMed
  47. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ 1992;305:548-53 «PMID: 1393033»PubMed
  48. Ferrante G, Rao SV, Jüni P ym. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv 2016;9:1419-34 «PMID: 27372195»PubMed
  49. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators., Yusuf S, Mehta SR ym. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76 «PMID: 16537663»PubMed
  50. Freemantle N, Cleland J, Young P ym. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999;318:1730-7 «PMID: 10381708»PubMed
  51. Fröbert O, Lagerqvist B, Olivecrona GK ym. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013;369:1587-97 «PMID: 23991656»PubMed
  52. Gershlick AH, Khan JN, Kelly DJ ym. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015;65:963-72 «PMID: 25766941»PubMed
  53. Gerstein HC, Colhoun HM, Dagenais GR ym. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet 2019;394:121-130 «PMID: 31189511»PubMed
  54. Gibson RS, Boden WE, Theroux P ym. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 1986;315:423-9 «PMID: 3526151»PubMed
  55. Gibson RS, Hansen JF, Messerli F ym. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies. Am J Cardiol 2000;86:275-9 «PMID: 10922432»PubMed
  56. Goldstein JA, Chinnaiyan KM, Abidov A ym. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J Am Coll Cardiol 2011;58:1414-22 «PMID: 21939822»PubMed
  57. Haaf P, Drexler B, Reichlin T ym. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012;126:31-40 «PMID: 22623715»PubMed
  58. Hernandez AF, Green JB, Janmohamed S ym. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet 2018;392:1519-1529 «PMID: 30291013»PubMed
  59. Hoedemaker NP, Roolvink V, de Winter RJ ym. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials. Eur Heart J Acute Cardiovasc Care 2020;9:469-477 «PMID: 30759994»PubMed
  60. Hoenig MR, Doust JA, Aroney CN ym. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006;:CD004815 «PMID: 16856061»PubMed
  61. Hoffmann U, Truong QA, Schoenfeld DA ym. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 2012;367:299-308 «PMID: 22830462»PubMed
  62. Holman RR, Bethel MA, Mentz RJ ym. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2017;377:1228-1239 «PMID: 28910237»PubMed
  63. Husain M, Birkenfeld AL, Donsmark M ym. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2019;381:841-851 «PMID: 31185157»PubMed
  64. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311-22 «PMID: 7905143»PubMed
  65. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999;354:708-15 «PMID: 10475181»PubMed
  66. Jobs A, Mehta SR, Montalescot G ym. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet 2017;390:737-746 «PMID: 28778541»PubMed
  67. Jobs A, Mehta SR, Montalescot G ym. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet 2017;390:737-746
  68. Jolly SS, Cairns JA, Yusuf S ym. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet 2016;387:127-35 «PMID: 26474811»PubMed
  69. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20 «PMID: 12517460»PubMed
  70. Kontos MC, Diercks DB, Ho PM ym. Treatment and outcomes in patients with myocardial infarction treated with acute ß-blocker therapy: results from the American College of Cardiology's NCDR(®). Am Heart J 2011;161:864-70 «PMID: 21570515»PubMed
  71. Kontos MC, McQueen RH, Jesse RL ym. Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 2001;37:431-8 «PMID: 11326177»PubMed
  72. Kontos MC, McQueen RH, Jesse RL ym. Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 2001;37:431-8
  73. Kristensen SL, Rørth R, Jhund PS ym. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol 2019;7:776-785 «PMID: 31422062»PubMed
  74. Lagerqvist B, Fröbert O, Olivecrona GK ym. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 2014;371:1111-20 «PMID: 25176395»PubMed
  75. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665 «PMID: 19454737»PubMed
  76. Lawes CM, Bennett DA, Feigin VL ym. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:776-85 «PMID: 14976329»PubMed
  77. Layland J, Oldroyd KG, Curzen N ym. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J 2015;36:100-11 «PMID: 25179764»PubMed
  78. Leivo J, Anttonen E, Jolly SS ym. The high-risk ECG pattern of ST-elevation myocardial infarction: A substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial). Int J Cardiol 2020;319:40-45 «PMID: 32470531»PubMed
  79. Lewis HD Jr, Davis JW, Archibald DG ym. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396-403 «PMID: 6135989»PubMed
  80. Liistro F, Angioli P, Falsini G ym. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome. Heart 2005;91:1284-8 «PMID: 15761051»PubMed
  81. Linde JJ, Kelbæk H, Hansen TF ym. Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. J Am Coll Cardiol 2020;75:453-463 «PMID: 32029126»PubMed
  82. Litt HI, Gatsonis C, Snyder B ym. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med 2012;366:1393-403 «PMID: 22449295»PubMed
  83. Lopes RD, Subherwal S, Holmes DN ym. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 2012;33:2044-53 «PMID: 22396323»PubMed
  84. Marso SP, Bain SC, Consoli A ym. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2016;375:1834-1844 «PMID: 27633186»PubMed
  85. Marso SP, Daniels GH, Brown-Frandsen K ym. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2016;375:311-22 «PMID: 27295427»PubMed
  86. Matetzky S, Freimark D, Chouraqui P ym. Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol 1998;31:506-11 «PMID: 9502627»PubMed
  87. McGuire DK, Shih WJ, Cosentino F ym. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis. JAMA Cardiol 2021;6:148-158 «PMID: 33031522»PubMed
  88. Mehta SR, Granger CB, Boden WE ym. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360:2165-75 «PMID: 19458363»PubMed
  89. Mehta SR, Tanguay JF, Eikelboom JW ym. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376:1233-43 «PMID: 20817281»PubMed
  90. Mehta SR, Wood DA, Storey RF ym. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med 2019;381:1411-1421 «PMID: 31475795»PubMed
  91. Melendez LJ, Jones DT, Salcedo JR. Usefulness of three additional electrocardiographic chest leads (V7, V8, and V9) in the diagnosis of acute myocardial infarction. Can Med Assoc J 1978;119:745-8 «PMID: 709476»PubMed
  92. Messerli FH, Hansen JF, Gibson RS ym. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients. J Hypertens 2001;19:977-82 «PMID: 11393682»PubMed
  93. Montalescot G, Cayla G, Collet JP ym. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA 2009;302:947-54 «PMID: 19724041»PubMed
  94. Montalescot G, Ellis SG, de Belder MA ym. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv 2010;3:203-12 «PMID: 20170878»PubMed
  95. Montalescot G, Sideris G, Meuleman C ym. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48:931-8 «PMID: 16949482»PubMed
  96. Montalescot G, Wiviott SD, Braunwald E ym. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31 «PMID: 19249633»PubMed
  97. Montelescot G. Intravenous enoxaparin associated with better ischaemic outcomes in primary PCI for STEMI than unfractionated heparin: results from the ATOLL study. European Society of Cardiology 2010 Congress
  98. Morrison LJ, Verbeek PR, McDonald AC ym. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 2000;283:2686-92 «PMID: 10819952»PubMed
  99. Narins CR. Treatment of coronary disease in elderly individuals. Cardiol J 2007;14:109-12 «PMID: 18651445»PubMed
  100. Neal B, Perkovic V, Mahaffey KW ym. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 2017;377:644-657 «PMID: 28605608»PubMed
  101. Neumann JT, Twerenbold R, Ojeda F ym. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. N Engl J Med 2019;380:2529-2540 «PMID: 31242362»PubMed
  102. Nikus K, Järvinen O, Sclarovsky S ym. Electrocardiographic presentation of left main disease in patients undergoing urgent or emergent coronary artery bypass grafting. Postgrad Med 2011;123:42-8 «PMID: 21474892»PubMed
  103. Nikus K. 12-lead Electrocardiogram in Acute Coronary Syndrome: Association with Coronary Angiography Findings and Outcome. Acta Universitatis Tamperensis; 1776, Tampere University Press, Tampere 2012
  104. Nikus KC, Eskola MJ, Virtanen VK ym. ST-depression with negative T waves in leads V4-V5--a marker of severe coronary artery disease in non-ST elevation acute coronary syndrome: a prospective study of Angina at rest, with troponin, clinical, electrocardiographic, and angiographic correlation. Ann Noninvasive Electrocardiol 2004;9:207-14 «PMID: 15245335»PubMed
  105. Nikus KC, Sclarovsky S, Huhtala H ym. Electrocardiographic presentation of global ischemia in acute coronary syndrome predicts poor outcome. Ann Med 2012;44:494-502 «PMID: 21679105»PubMed
  106. Nunn CM, O'Neill WW, Rothbaum D ym. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol 1999;33:640-6 «PMID: 10080463»PubMed
  107. Ozasa N, Kimura T, Morimoto T ym. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol 2010;106:1225-33 «PMID: 21029817»PubMed
  108. Pahor M, Psaty BM, Alderman MH ym. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356:1949-54 «PMID: 11130522»PubMed
  109. Perkovic V, Jardine MJ, Neal B ym. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med 2019;380:2295-2306 «PMID: 30990260»PubMed
  110. Pfeffer MA, Claggett B, Diaz R ym. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med 2015;373:2247-57 «PMID: 26630143»PubMed
  111. Pinto DS, Kirtane AJ, Nallamothu BK ym. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006;114:2019-25 «PMID: 17075010»PubMed
  112. Psaty BM, Lumley T, Furberg CD ym. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-44 «PMID: 12759325»PubMed
  113. Puymirat E, Cayla G, Simon T ym. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. N Engl J Med 2021;385:297-308 «PMID: 33999545»PubMed
  114. Rauch B, Davos CH, Doherty P ym. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol 2016;23:1914-1939 «PMID: 27777324»PubMed
  115. Rawles JM. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1997;30:1181-6 «PMID: 9350912»PubMed
  116. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990;336:827-30 «PMID: 1976875»PubMed
  117. Romero-Díaz J, Vargas-Vóracková F, Kimura-Hayama E ym. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology (Oxford) 2012;51:110-9 «PMID: 22039268»PubMed
  118. Sabatine MS, Cannon CP, Gibson CM ym. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89 «PMID: 15758000»PubMed
  119. Safi S, Sethi NJ, Nielsen EE ym. Beta-blockers for suspected or diagnosed acute myocardial infarction. Cochrane Database Syst Rev 2019;12:CD012484 «PMID: 31845756»PubMed
  120. Samad Z, Hakeem A, Mahmood SS ym. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department. J Nucl Cardiol 2012;19:364-76 «PMID: 22322526»PubMed
  121. Samad Z, Hakeem A, Mahmood SS ym. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department. J Nucl Cardiol 2012;19:364-76 «PMID: 22322526»PubMed
  122. Sandoval Y, Nowak R, deFilippi CR ym. Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I. J Am Coll Cardiol 2019;74:271-282 «PMID: 31319909»PubMed
  123. Sandoval Y, Smith SW, Love SA ym. Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction. Am J Med 2017;130:1076-1083.e1 «PMID: 28344141»PubMed
  124. Schofer J, Büttner J, Geng G ym. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990;66:1429-33 «PMID: 2251987»PubMed
  125. Sclarovsky S, Rechavia E, Strasberg B ym. Unstable angina: ST segment depression with positive versus negative T wave deflections--clinical course, ECG evolution, and angiographic correlation. Am Heart J 1988;116:933-41 «PMID: 3177193»PubMed
  126. Sejersten M, Ripa RS, Maynard C ym. Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy. Am Heart J 2007;154:61.e1-8 «PMID: 17584552»PubMed
  127. Sels JW, Tonino PA, Siebert U ym. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv 2011;4:1183-9 «PMID: 22115657»PubMed
  128. Sgarbossa EB, Pinski SL, Barbagelata A ym. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 1996;334:481-7 «PMID: 8559200»PubMed
  129. Smits PC, Abdel-Wahab M, Neumann FJ ym. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med 2017;376:1234-1244 «PMID: 28317428»PubMed
  130. Snaterse M, Dobber J, Jepma P ym. Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis. Heart 2016;102:50-6 «PMID: 26567234»PubMed
  131. Steg PG, Bonnefoy E, Chabaud S ym. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6 «PMID: 14623806»PubMed
  132. Steg PG, James S, Harrington RA ym. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 2010;122:2131-41 «PMID: 21060072»PubMed
  133. Stenestrand U, Lindbäck J, Wallentin L ym. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56 «PMID: 17032988»PubMed
  134. Suaya JA, Stason WB, Ades PA ym. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol 2009;54:25-33 «PMID: 19555836»PubMed
  135. Svensson L, Aasa M, Dellborg M ym. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J 2006;151:798.e1-7 «PMID: 16569536»PubMed
  136. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology., Bassand JP, Hamm CW ym. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660 «PMID: 17569677»PubMed
  137. Taylor RS, Brown A, Ebrahim S ym. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92 «PMID: 15121495»PubMed
  138. Tegn N, Abdelnoor M, Aaberge L ym. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016;387:1057-1065 «PMID: 26794722»PubMed
  139. Théroux P, Ouimet H, McCans J ym. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11 «PMID: 3050522»PubMed
  140. Thiele H, Rach J, Klein N ym. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 2012;33:2035-43 «PMID: 22108830»PubMed
  141. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration.. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35 «PMID: 14615107»PubMed
  142. Ungprasert P, Charoenpong P, Ratanasrimetha P ym. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 2014;33:1099-104 «PMID: 24859783»PubMed
  143. Van Belle E, Baptista SB, Raposo L ym. Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice). Circ Cardiovasc Interv 2017;10: «PMID: 28615234»PubMed
  144. Wald DS, Morris JK, Wald NJ ym. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013;369:1115-23 «PMID: 23991625»PubMed
  145. Wallentin LC. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. J Am Coll Cardiol 1991;18:1587-93 «PMID: 1960301»PubMed
  146. Wallert J, Olsson EM, Pingel R ym. Attending Heart School and long-term outcome after myocardial infarction: A decennial SWEDEHEART registry study. Eur J Prev Cardiol 2020;27:145-154 «PMID: 31514507»PubMed
  147. Weaver WD, Cerqueira M, Hallstrom AP ym. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-6 «PMID: 8355383»PubMed
  148. Widimsky P, Bilkova D, Penicka M ym. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. Eur Heart J 2007;28:679-84 «PMID: 17298968»PubMed
  149. Widimský P, Budesínský T, Vorác D ym. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. Eur Heart J 2003;24:94-104 «PMID: 12559941»PubMed
  150. Wiviott SD, Raz I, Bonaca MP ym. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 2019;380:347-357 «PMID: 30415602»PubMed
  151. Yiu KH, Mok MY, Wang S ym. Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2012;30:345-50 «PMID: 22409930»PubMed
  152. Zalenski RJ, Cooke D, Rydman R ym. Assessing the diagnostic value of an ECG containing leads V4R, V8, and V9: the 15-lead ECG. Ann Emerg Med 1993;22:786-93 «PMID: 8470834»PubMed
  153. Zijlstra F, Hoorntje JC, de Boer MJ ym. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9 «PMID: 10547403»PubMed
  154. Zinman B, Wanner C, Lachin JM ym. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 2015;373:2117-28 «PMID: 26378978»PubMed
Artikkelin tunnus: nix03013 (050.130)
© 2024 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit